RegASK, a worldwide RegTech SaaS startup, announced today that it has raised a USD 10 million Series A fundraising round. Monograph Capital led the round, which was supported by SPRIM Global Investments and other investors. The funds will be utilized to expand the platform and deliver RegASK to all firms looking to improve their regulatory skills throughout the world. The financing comes on the heels of the RegASK platform being expanded to serve additional industries such as biopharma and decentralized clinical trials regulation, in addition to the existing deployments in consumer health, medtech, and food.
RegASK provides businesses with relevant, curated, and easy-to-access regulatory information, allowing them to cut through the clutter and complexity of an ever-increasing number of new rules. RegASK employs artificial intelligence to keep up with the ever-changing regulatory landscape.
RegASK’s technology platform routinely monitors, curates, and automatically summaries laws for biopharma, CROs, consumer health, medical device, and food firms throughout the world. Additionally, the platform delivers in-depth insights on rules and anticipated regulatory changes, as well as connecting firms with over 400+ subject matter experts in 100+ countries for strategy and planning.
RegASK CEO Caroline Shleifer, PhD:
“The inclusion of Monograph Capital is important to RegASK’s future path. The RegASK AI-powered platform provides businesses with an innovative and user-friendly solution for reducing regulatory monitoring and compliance obligations. The leadership of Monograph provides a deep industry awareness of the demands of life science and CRO firms.”
Monograph Partner Charles Conn stated:
“RegASK is a fantastically innovative approach to the burgeoning regulatory strategy and compliance space, using artificial intelligence to streamline information capture and planning for pharmaceutical companies, clinical research organizations, and many other segments. The monograph is thrilled to be a part of the company’s expansion.”
About the company:
RegASK, which was founded in 2018, is a regtech SaaS platform that enables organizations to use AI to grow their regulatory and compliance capabilities. Businesses may readily access essential regulatory material that has been automatically recognized and curated using RegASK. The platform keeps you up to date with automated RegAlertsTM and gives you access to a network of 400+ subject matter experts in over 100 countries across the world.
We try our best to fact-check and bring the best, well-researched, and non-plagiarized content to you. Please let us know
-if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
